These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV). Hagopian GS, Mills GB, Khokhar AR, Bast RC, Siddik ZH. Clin Cancer Res; 1999 Mar 15; 5(3):655-63. PubMed ID: 10100719 [Abstract] [Full Text] [Related]
10. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544 [Abstract] [Full Text] [Related]
11. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells. Kagawa S, Fujiwara T, Hizuta A, Yasuda T, Zhang WW, Roth JA, Tanaka N. Oncogene; 1997 Oct 16; 15(16):1903-9. PubMed ID: 9365236 [Abstract] [Full Text] [Related]
13. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Elbendary A, Berchuck A, Davis P, Havrilesky L, Bast RC, Iglehart JD, Marks JR. Cell Growth Differ; 1994 Dec 16; 5(12):1301-7. PubMed ID: 7696178 [Abstract] [Full Text] [Related]
15. Loss of inhibitor of apoptosis proteins as a determinant of polyamine analog-induced apoptosis in human melanoma cells. Chen Y, Kramer DL, Li F, Porter CW. Oncogene; 2003 Aug 07; 22(32):4964-72. PubMed ID: 12902979 [Abstract] [Full Text] [Related]
17. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion. Bernacki RJ, Oberman EJ, Seweryniak KE, Atwood A, Bergeron RJ, Porter CW. Clin Cancer Res; 1995 Aug 07; 1(8):847-57. PubMed ID: 9816054 [Abstract] [Full Text] [Related]
18. p53-mediated accumulation of hypophosphorylated pRb after the G1 restriction point fails to halt cell cycle progression. Linke SP, Harris MP, Neugebauer SE, Clarkin KC, Shepard HM, Maneval DC, Wahl GM. Oncogene; 1997 Jul 17; 15(3):337-45. PubMed ID: 9233768 [Abstract] [Full Text] [Related]
19. Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint. Howard SP, Park SJ, Hughes-Davies L, Coleman CN, Price BD. Clin Cancer Res; 1996 Feb 17; 2(2):269-76. PubMed ID: 9816169 [Abstract] [Full Text] [Related]
20. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line. Saied IT, Shamsuddin AM. Anticancer Res; 1998 Feb 17; 18(3A):1479-84. PubMed ID: 9673359 [Abstract] [Full Text] [Related] Page: [Next] [New Search]